News

(RTTNews) - Chemical company DuPont de Nemours, Inc. or DuPont (DD) announced Tuesday it has signed an agreement to acquire Donatelle Plastics Inc., a medical device contract manufacturer specializing in the design, development and manufacture of medical components and devices.

The transaction is expected to close in the third quarter 2024, subject to satisfaction of customary closing conditions and receipt of regulatory approvals.

DuPont's healthcare exposure within the Industrial Solutions line of business of the E&I segment includes Spectrum, a leader in medical device components, and Liveo, a leader in silicone solutions for healthcare applications.

The acquisition of Donatelle Plastics will bring complementary advanced technologies and capabilities including medical device injection molding, liquid silicone rubber processing, precision machining, device assembly, and tool building.

Donatelle Plastics has a strong financial growth profile aligned to attractive therapeutic areas including electrophysiology, drug delivery, diagnostics, cardiac rhythm management, neurostimulation, and orthopedic extremities.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.